It also reduces inflammation, which can significantly lower pain levels and promote long-term relief
Frequency changes across the cycle, not the dose size
The compounds name refers to Body Protection Compound-157, reflecting observed effects in experimental systems rather than endogenous occurrence
ClinicalTrials.gov , 2015
With 100 mg/mL, 0.3 mL = 30 mg (because 100 mg 0.3 mL = 30 mg )

Studies have shown that BPC-157 [8]: Modulates GABA receptor function Influences dopaminergic system activity Affects serotonergic pathways May help normalize neurotransmitter imbalances caused by various toxins These effects contribute to BPC-157's observed: Anxiolytic (anti-anxiety) properties in animal models Protection against dopaminergic neurotoxins Potential applications in alcohol withdrawal and drug-induced neurological damage Gut motility regulation Angiogenesis Promotion Beyond VEGF upregulation, BPC-157 promotes angiogenesis through multiple coordinated mechanisms [9]: Direct stimulation of endothelial cell proliferation Enhanced endothelial cell migration Improved capillary tube formation Blood vessel maturation and stabilization Collateral vessel development around blocked arteries This robust angiogenic effect helps explain why BPC-157 appears effective for tissues with naturally poor blood supply (tendons, ligaments, cartilage) and why it may support recovery from ischemic injuries
